BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35176941)

  • 21. PES1 is transcriptionally regulated by BRD4 and promotes cell proliferation and glycolysis in hepatocellular carcinoma.
    Fan P; Wang B; Meng Z; Zhao J; Jin X
    Int J Biochem Cell Biol; 2018 Nov; 104():1-8. PubMed ID: 30172011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA Ftx promotes aerobic glycolysis and tumor progression through the PPARĪ³ pathway in hepatocellular carcinoma.
    Li X; Zhao Q; Qi J; Wang W; Zhang D; Li Z; Qin C
    Int J Oncol; 2018 Aug; 53(2):551-566. PubMed ID: 29845188
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RFX6 facilitates aerobic glycolysis-mediated growth and metastasis of hepatocellular carcinoma through targeting PGAM1.
    Qiu Z; Wang C; Huang P; Yuan Y; Shi Y; Lin Z; Huang Z; Zuo D; Qiu J; He W; Shen J; Niu Y; Yuan Y; Li B
    Clin Transl Med; 2023 Dec; 13(12):e1511. PubMed ID: 38093528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
    Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
    Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA LINC01139 promotes the progression of hepatocellular carcinoma by upregulating MYBL2 via competitively binding to miR-30 family.
    Li ZB; Chu HT; Jia M; Li L
    Biochem Biophys Res Commun; 2020 May; 525(3):581-588. PubMed ID: 32115147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3.
    Liu W; Shen D; Ju L; Zhang R; Du W; Jin W; Xiong K; Wang G; Qian K; Zhang Y; Xiao Y; Wang X
    Oncogene; 2022 Oct; 41(41):4606-4617. PubMed ID: 36071275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET.
    He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L
    Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer.
    Li Q; Wang M; Hu Y; Zhao E; Li J; Ren L; Wang M; Xu Y; Liang Q; Zhang D; Lai Y; Liu S; Peng X; Zhu C; Ye L
    Theranostics; 2021; 11(12):5794-5812. PubMed ID: 33897882
    [No Abstract]   [Full Text] [Related]  

  • 30. UPF1 inhibits the hepatocellular carcinoma progression by targeting long non-coding RNA UCA1.
    Zhou Y; Li Y; Wang N; Li X; Zheng J; Ge L
    Sci Rep; 2019 Apr; 9(1):6652. PubMed ID: 31040354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/ERK pathway.
    He H; Chen T; Mo H; Chen S; Liu Q; Guo C
    Biochem Biophys Res Commun; 2020 Dec; 533(4):886-892. PubMed ID: 33008585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eukaryotic translation initiation factor 5A2 promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Cao TT; Lin SH; Fu L; Tang Z; Che CM; Zhang LY; Ming XY; Liu TF; Tang XM; Tan BB; Xiang D; Li F; Chan OY; Xie D; Cai Z; Guan XY
    Carcinogenesis; 2017 Jan; 38(1):94-104. PubMed ID: 27879277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
    Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
    Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of PCK1 Gene Antagonizes Hepatocellular Carcinoma Through the Activation of Gluconeogenesis and Suppression of Glycolysis Pathways.
    Tang Y; Zhang Y; Wang C; Sun Z; Li L; Cheng S; Zhou W
    Cell Physiol Biochem; 2018; 47(1):344-355. PubMed ID: 29768256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXP2 suppresses the proliferation, invasion, and aerobic glycolysis of hepatocellular carcinoma cells by regulating the KDM5A/FBP1 axis.
    Yan L; Sun H; Chen Y; Yu X; Zhang J; Li P
    Environ Toxicol; 2024 Jan; 39(1):341-356. PubMed ID: 37713600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIWIL1 governs the crosstalk of cancer cell metabolism and immunosuppressive microenvironment in hepatocellular carcinoma.
    Wang N; Tan HY; Lu Y; Chan YT; Wang D; Guo W; Xu Y; Zhang C; Chen F; Tang G; Feng Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):86. PubMed ID: 33633112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-induced elevated NDRG1 mediates apoptosis through reprograming mitochondrial fission in HCC.
    Guo DD; Xie KF; Luo XJ
    Gene; 2020 May; 741():144552. PubMed ID: 32165297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
    Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
    J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High mobility group protein B1 controls liver cancer initiation through yes-associated protein -dependent aerobic glycolysis.
    Chen R; Zhu S; Fan XG; Wang H; Lotze MT; Zeh HJ; Billiar TR; Kang R; Tang D
    Hepatology; 2018 May; 67(5):1823-1841. PubMed ID: 29149457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. METTL3 expression is associated with glycolysis metabolism and sensitivity to glycolytic stress in hepatocellular carcinoma.
    Lin Y; Wei X; Jian Z; Zhang X
    Cancer Med; 2020 Apr; 9(8):2859-2867. PubMed ID: 32068977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.